SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Procter&Gamble Healt - Quaterly Results

04 Nov 2024 Evaluate
With no major difference for the quarter endedSeptember 2024 , the total revenue stood at Rs. 3134.10  millions.An average growth of 25.56% was recorded for the quarter ended September 2024 to Rs. 823.30  millions from Rs. 655.70 millions.Operating profit for the quarter ended September 2024 rose to 1173.20 millions as compared to 947.10 millions of corresponding quarter ended September 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202406 202306 % Var
Sales 3134.10 3049.30 2.78 3134.10 3049.30 2.78 11512.60 12296.20 -6.37
Other Income 32.80 60.50 -45.79 32.80 60.50 -45.79 156.30 183.90 -15.01
PBIDT 1173.20 947.10 23.87 1173.20 947.10 23.87 3216.30 3430.70 -6.25
Interest 1.50 1.80 -16.67 1.50 1.80 -16.67 7.20 7.70 -6.49
PBDT 1171.70 945.30 23.95 1171.70 945.30 23.95 3007.20 3423.00 -12.15
Depreciation 57.70 64.80 -10.96 57.70 64.80 -10.96 274.00 281.00 -2.49
PBT 1114.00 880.50 26.52 1114.00 880.50 26.52 2733.20 3142.00 -13.01
TAX 290.70 224.80 29.31 290.70 224.80 29.31 723.40 847.30 -14.62
Deferred Tax 11.20 1.90 489.47 11.20 1.90 489.47 -86.00 -50.60 69.96
PAT 823.30 655.70 25.56 823.30 655.70 25.56 2009.80 2294.70 -12.42
Equity 166.00 166.00 0.00 166.00 166.00 0.00 166.00 166.00 0.00
PBIDTM(%) 37.43 31.06 20.52 37.43 31.06 20.52 27.94 27.90 0.13

Procter&Gamble Healt Share Price

5021.30 29.00 (0.58%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×